Nikhil Lalwani - 26 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
26 Feb 2026
Net transactions value
+$4,929,086
Form type
4
Filing time
02 Mar 2026, 17:58:54 UTC
Previous filing
17 Feb 2026
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lalwani Nikhil PRESIDENT & CEO, Director C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook 02 Mar 2026 0001822629

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Award $5,831,923 +75,592 +21% $77.15 434,166 26 Feb 2026 Direct F1
transaction ANIP Common Stock Tax liability $902,836 -12,217 -2.8% $73.90 421,949 28 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 23,883 shares of restricted stock, the grant of which was previously reported.